Ultragenyx Pharmaceutical Inc. (RARE)

CIK 1515673 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ultragenyx Pharmaceutical Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202610-Q0001193125-26-445718
Nov 3, 20268-K0001193125-26-445342
Oct 30, 2026SCHEDULE 13G/A0002100121-26-001144
Oct 20, 2026SCHEDULE 13G0001013594-26-001062
Oct 19, 202640001193125-26-425032
Oct 19, 20268-K0001193125-26-424739
Oct 14, 20268-K0001193125-26-421079
Oct 7, 20268-K0001193125-26-416251
Sep 17, 20268-K0001515673-26-000006
Sep 15, 20261440001950047-26-009497
Sep 15, 202640001193125-26-392233
Sep 8, 202640001193125-26-384878
Sep 2, 20268-K0001193125-26-380165
Aug 19, 20268-K0001193125-26-357185
Aug 14, 2026SCHEDULE 13G0001493215-26-000161
Aug 13, 2026SCHEDULE 13G0001167557-26-000169
Aug 11, 20268-K0001193125-26-343525
Aug 7, 2026SCHEDULE 13G0000093751-26-000549
Aug 5, 202610-Q0001193125-26-333233
Aug 4, 202640001193125-26-332547
Aug 4, 20268-K0001193125-26-332802
Aug 4, 202640001193125-26-332536
Aug 3, 20261440001950047-26-007510
Jul 31, 2026SCHEDULE 13G0002100119-26-001487
Jul 31, 2026SCHEDULE 13G/A0002100121-26-001001